| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |